BSF Enterprise Plc (BSFAF)
| Market Cap | 3.38M |
| Revenue (ttm) | 77.50K |
| Net Income (ttm) | -2.24M |
| Shares Out | n/a |
| EPS (ttm) | -0.02 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 10,000 |
| Average Volume | 3,110 |
| Open | 0.0350 |
| Previous Close | n/a |
| Day's Range | 0.0350 - 0.0350 |
| 52-Week Range | 0.0200 - 0.0584 |
| Beta | 2.64 |
| RSI | n/a |
| Earnings Date | Sep 10, 2025 |
About BSF Enterprise
BSF Enterprise Plc develops and commercializes cutting-edge tissue-engineered solutions. It offers lab-grown leather, cultivated meat, and corneal repair technologies. The company was incorporated in 2018 and is based in London, United Kingdom. [Read more]
Financial Performance
In 2024, BSF Enterprise's revenue was 57,821, an increase of 346.77% compared to the previous year's 12,942. Losses were -1.67 million, 11.4% more than in 2023.
Financial numbers in GBP Financial StatementsNews
BSF Enterprise PLC Announces Participation in The ThinkEquity Conference
London, United Kingdom--(Newsfile Corp. - October 5, 2023) - BSF Enterprise PLC (LSE: BSFA) (OTCQB: BSFAF), a company focused on unlocking the next generation of biotechnological solutions using cell-...
BSF Enterprise PLC Provides City-MixTM Bio-Pharmaceutical Update
LONDON, July 18, 2023 (GLOBE NEWSWIRE) -- BSF Enterprise PLC ("BSF" or the "Company") (LSE: BSFA), (OTCQB: BSFAF), a company focused on unlocking the next generation of biotechnological solutions usin...